CIK 0001434647
- Non-accelerated filer
- Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205894398
- Phone
- +1 888-958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $7.96 ($79,624)
- 4 Planned sale SVP, Finance & Corp Controller sold 3,000 shares at $7.86 ($23,588)
- 4 Planned sale CCO & EVP, Bus. Development sold 10,500 shares at $7.86 ($82,527)
- 4 Planned sale CFO & Treasurer sold 11,000 shares at $7.86 ($86,471)
- 4 Planned sale President and CEO sold 91,817 shares at an average $7.92 ($727,390)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion SVP, Finance & Corp Controller acquired 11,666 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion CCO & EVP, Bus. Development acquired 35,333 shares (option exercise)
- 4 Exercise or conversion CFO & Treasurer acquired 43,333 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 233,333 shares (option exercise)
- 4 Open-market buy Director bought 500 shares at $7.92 ($3,958)
- 4 Open-market buy CFO & Treasurer bought 2,000 shares at $6.77 ($13,540)
- 4 Open-market buy Director bought 10,000 shares at $6.81 ($68,065)
- 4 Open-market buy Director bought 10,000 shares at $5.87 ($58,661)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 3 of 16 · 314 filings